In patients who already present with obesity-related complications, pharmacologic therapy should be considered as a first-line option alongside lifestyle intervention, without postponing treatment until lifestyle approaches have failed
Continuous glucose monitoring We are starting to see wider uptake of continuous glucose monitoring (CGM) in people with type 2 diabetes on insulin, and hopefully our confidence to initiate and support individuals within our practices is growing
See also: GLP-1 Guides | Peptide Guides Written by James Whitfield, CSCS , Exercise Physiologist & Performance Researcher Medically reviewed by FormBlends Clinical Review , Clinical Pharmacist & Medical Reviewer Published: Key Takeaway Compare BPC-157 and GHK-Cu peptides: healing mechanisms, clinical efficacy, side effects, and costs
Essential elements of a legitimate COA Every credible retatrutide COA should include a batch number that uniquely identifies the production run
The question becomes: how can we maximize positive outcomes while minimizing financial strain